Correlation Between Viridian Therapeutics and ICON PLC
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and ICON PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and ICON PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and ICON PLC, you can compare the effects of market volatilities on Viridian Therapeutics and ICON PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of ICON PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and ICON PLC.
Diversification Opportunities for Viridian Therapeutics and ICON PLC
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viridian and ICON is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and ICON PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ICON PLC and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with ICON PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ICON PLC has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and ICON PLC go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and ICON PLC
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 0.71 times more return on investment than ICON PLC. However, Viridian Therapeutics is 1.41 times less risky than ICON PLC. It trades about -0.19 of its potential returns per unit of risk. ICON PLC is currently generating about -0.21 per unit of risk. If you would invest 2,339 in Viridian Therapeutics on August 24, 2024 and sell it today you would lose (377.00) from holding Viridian Therapeutics or give up 16.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. ICON PLC
Performance |
| Timeline |
| Viridian Therapeutics |
| ICON PLC |
Viridian Therapeutics and ICON PLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and ICON PLC
The main advantage of trading using opposite Viridian Therapeutics and ICON PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, ICON PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ICON PLC will offset losses from the drop in ICON PLC's long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| ICON PLC vs. Mettler Toledo International | ICON PLC vs. Charles River Laboratories | ICON PLC vs. Laboratory of | ICON PLC vs. IQVIA Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |